- Home
- TNXP vs HTOO Comparison
TNXP vs HTOO Comparison
Compare TNXP & HTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- HTOO
- Stock Information
- Founded
- TNXP 2007
- HTOO 2020
- Country
- TNXP United States
- HTOO Ireland
- Employees
- TNXP N/A
- HTOO N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- HTOO Natural Gas Distribution
- Sector
- TNXP Health Care
- HTOO Utilities
- Exchange
- TNXP Nasdaq
- HTOO Nasdaq
- Market Cap
- TNXP 15.1M
- HTOO 12.3M
- IPO Year
- TNXP N/A
- HTOO N/A
- Fundamental
- Price
- TNXP $0.15
- HTOO $0.54
- Analyst Decision
- TNXP Strong Buy
- HTOO Buy
- Analyst Count
- TNXP 2
- HTOO 2
- Target Price
- TNXP $53.50
- HTOO $3.25
- AVG Volume (30 Days)
- TNXP 26.1M
- HTOO 162.1K
- Earning Date
- TNXP 11-07-2024
- HTOO 12-02-2024
- Dividend Yield
- TNXP N/A
- HTOO N/A
- EPS Growth
- TNXP N/A
- HTOO N/A
- EPS
- TNXP N/A
- HTOO N/A
- Revenue
- TNXP $12,458,000.00
- HTOO $4,580,524.00
- Revenue This Year
- TNXP $62.53
- HTOO $440.97
- Revenue Next Year
- TNXP $26.17
- HTOO $214.20
- P/E Ratio
- TNXP N/A
- HTOO N/A
- Revenue Growth
- TNXP N/A
- HTOO N/A
- 52 Week Low
- TNXP $0.12
- HTOO $0.46
- 52 Week High
- TNXP $22.08
- HTOO $4.65
- Technical
- Relative Strength Index (RSI)
- TNXP 32.40
- HTOO 44.88
- Support Level
- TNXP $0.14
- HTOO $0.50
- Resistance Level
- TNXP $0.18
- HTOO $0.56
- Average True Range (ATR)
- TNXP 0.02
- HTOO 0.05
- MACD
- TNXP 0.02
- HTOO 0.01
- Stochastic Oscillator
- TNXP 28.11
- HTOO 64.35
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About HTOO Fusion Fuel Green PLC
Fusion Fuel Green PLC is a company that has developed a Green Hydrogen production technology. It is focused on generating cost-effective and competitively priced Green Hydrogen.